相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Down-Regulation of DUSP6 Expression in Lung Cancer Its Mechanism and Potential Role in Carcinogenesis
Koji Okudela et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Dual-specificity phosphatases: critical regulators with diverse cellular targets
Kate I. Patterson et al.
BIOCHEMICAL JOURNAL (2009)
Negative and Positive Regulation of MAPK Phosphatase 3 Controls Platelet-derived Growth Factor-induced Erk Activation
Aleksandra Jurek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Feedback regulation of DUSP6 transcription responding to MAPK1 via ETS2 in human cells
Toru Furukawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Negative-feedback regulation of FGF signalling by DUSP6/MKP-3 is driven by ERK1/2 and mediated by Ets factor binding to a conserved site within the DUSP6/MKP-3 gene promoter
Maria Ekerot et al.
BIOCHEMICAL JOURNAL (2008)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Dual-specificity MAP kinase phosphatases (MKPs) and cancer
Stephen M. Keyse
CANCER AND METASTASIS REVIEWS (2008)
15-hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3β and a tumor suppressor in lung cancer
Guosheng Huang et al.
CANCER RESEARCH (2008)
Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells
David W. Chan et al.
CARCINOGENESIS (2008)
Gene expression analysis of BCR/ABLI-dependent transcriptional response reveals genes involved in negative enrichment for feedback regulation
Petra Hikansson et al.
GENES CHROMOSOMES & CANCER (2008)
DUSP6 (MKP3) Null Mice Show Enhanced ERK1/2 Phosphorylation at Baseline and Increased Myocyte Proliferation in the Heart Affecting Disease Susceptibility
Marjorie Maillet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Structure and clinical relevance of the epidermal growth factor receptor in human cancer
Amit Kumar et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Annual Report to the Nation on the Status of Cancer, 1975-2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control
Ahmedin Jemal et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Post-translational regulation of the ERK phosphatase DUSP6/MKP3 by the mTOR pathway
O. Bermudez et al.
ONCOGENE (2008)
Resistance to an irreversible epidermal growth factor receptor (EGFR) inhibitor in EGFR-Mutant lung cancer reveals novel treatment strategies
Zhiwei Yu et al.
CANCER RESEARCH (2007)
MAP kinase phosphatase activity for thymocyte positive selection sets the threshold
Matthew L. Bettini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
MAP kinase signalling pathways in cancer
A. S. Dhillon et al.
ONCOGENE (2007)
Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses
Kate L. Jeffrey et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
A five-gene signature and clinical outcome in non-small-cell lung cancer
Hsuan-Yu Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development
Chaoying Li et al.
DEVELOPMENT (2007)
Mapping ERK2-MKP3 binding interfaces by hydrogen/deuterium exchange mass spectrometry
Bo Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling
Susumu Kobayashi et al.
CANCER RESEARCH (2006)
Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells
DB Ramnarain et al.
CANCER RESEARCH (2006)
An alternative inhibitor overcomes resistance caused by a mutation of the epidermal growth factor receptor
S Kobayashi et al.
CANCER RESEARCH (2005)
Erlotinib in previously treated non-small-cell lung cancer
FA Shepherd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines
S Bloethner et al.
CARCINOGENESIS (2005)
The noncatalytic amino terminus of mitogen-activated protein kinase phosphatase 1 directs nuclear targeting and serum response element transcriptional regulation
JJ Wu et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib
EL Kwak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Abrogation of DUSP6 by hypermethylation in human pancreatic cancer
SH Xu et al.
JOURNAL OF HUMAN GENETICS (2005)
Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer
E Myers et al.
CLINICAL CANCER RESEARCH (2005)
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
W Pao et al.
PLOS MEDICINE (2005)
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
S Kobayashi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib
W Pao et al.
PLOS MEDICINE (2005)
Mkp3 is a negative feedback modulator of Fgf8 signaling in the mammalian isthmic organizer
D Echevarria et al.
DEVELOPMENTAL BIOLOGY (2005)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mitogen-activated protein kinase phosphatase-3 is a tumor promoter target in initiated cells that express oncogenic Ras
JK Warmka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Structure and regulation of MAPK phosphatases
A Farooq et al.
CELLULAR SIGNALLING (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice
[Anonymous]
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
MKP-7, a novel mitogen-activated protein kinase phosphatase, functions as a shuttle protein
K Masuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
